| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 436 | 2021 |
| LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... BioRxiv, 2020.09. 30.318972, 2020 | 151 | 2020 |
| A Comparative Analysis of SARS-CoV-2 Antivirals Characterizes 3CLpro Inhibitor PF-00835231 as a Potential New Treatment for COVID-19 M de Vries, AS Mohamed, RA Prescott, AM Valero-Jimenez, L Desvignes, ... Journal of Virology 95 (10), 10.1128/jvi. 01819-20, 2021 | 141 | 2021 |
| Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses LC Nguyen, D Yang, V Nicolaescu, TJ Best, H Gula, D Saxena, ... Science Advances 8 (8), eabi6110, 2022 | 121 | 2022 |
| Novel high-throughput approach for purification of infectious virions KT James, B Cooney, K Agopsowicz, MA Trevors, A Mohamed, D Stoltz, ... Scientific reports 6 (1), 36826, 2016 | 71 | 2016 |
| Cannabidiol inhibits SARS-CoV-2 replication and promotes the host innate immune response LC Nguyen, D Yang, V Nicolaescu, TJ Best, T Ohtsuki, SN Chen, ... BioRxiv, 2021 | 59 | 2021 |
| The ETS transcription factor ELF1 regulates a broadly antiviral program distinct from the type I interferon response LL Seifert, C Si, D Saha, M Sadic, M de Vries, S Ballentine, A Briley, ... PLoS pathogens 15 (11), e1007634, 2019 | 53 | 2019 |
| Reovirus variants with mutations in genome segments S1 and L2 exhibit enhanced virion infectivity and superior oncolysis M Shmulevitz, SA Gujar, DG Ahn, A Mohamed, PWK Lee Journal of virology 86 (13), 7403-7413, 2012 | 43 | 2012 |
| Potential for improving potency and specificity of reovirus oncolysis with next-generation reovirus variants A Mohamed, RN Johnston, M Shmulevitz Viruses 7 (12), 6251-6278, 2015 | 41 | 2015 |
| Epigenetic Differences between Human Papillomavirus--Positive and--Negative Oropharyngeal Squamous Cell Carcinomas. VL Biron, A Mohamed, MJ Hendzel, DA Underhill, H Seikaly Journal of Otolaryngology--Head & Neck Surgery 41, 2012 | 38 | 2012 |
| Reduction of virion-associated σ1 fibers on oncolytic reovirus variants promotes adaptation toward tumorigenic cells A Mohamed, C Teicher, S Haefliger, M Shmulevitz Journal of virology 89 (8), 4319-4334, 2015 | 28 | 2015 |
| Genetic variation of staphylococcal LukAB toxin determines receptor tropism SS Perelman, DBA James, KM Boguslawski, CW Nelson, JK Ilmain, ... Nature microbiology 6 (6), 731-745, 2021 | 25 | 2021 |
| Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency In Vitro and In Vivo A Mohamed, DR Clements, SA Gujar, PW Lee, JR Smiley, M Shmulevitz Journal of Virology 94 (4), 10.1128/jvi. 01688-19, 2020 | 25 | 2020 |
| Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus-independent host genes, via mechanisms of slow replication versus polymorphisms in … A Mohamed, P Konda, HE Eaton, S Gujar, JR Smiley, M Shmulevitz PLoS Pathogens 16 (9), e1008803, 2020 | 24 | 2020 |
| Polymorphisms in the most oncolytic reovirus strain confer enhanced cell attachment, transcription, and single-step replication kinetics A Mohamed, JR Smiley, M Shmulevitz Journal of Virology 94 (4), 10.1128/jvi. 01937-19, 2020 | 23 | 2020 |
| Comparative study of a 3CLpro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models M de Vries, AS Mohamed, RA Prescott, AM Valero-Jimenez, L Desvignes, ... bioRxiv 95 (10), 1819-20, 2020 | 22 | 2020 |
| SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells LC Nguyen, DM Renner, D Silva, D Yang, NA Parenti, KM Medina, ... Mbio 13 (5), e02415-22, 2022 | 19 | 2022 |
| A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression DM Santer, GES Minty, A Mohamed, L Baldwin, R Bhat, M Joyce, A Egli, ... Journal of immunological methods 445, 15-22, 2017 | 7 | 2017 |
| Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity CA Menendez, A Mohamed, GR Perez-Lemus, AM Weiss, BW Rawe, ... Molecules 28 (18), 6643, 2023 | 2 | 2023 |
| p38 Mitogen-Activated Protein Kinase Signaling Enhances Reovirus Replication by Facilitating Efficient Virus Entry, Capsid Uncoating, and Postuncoating Steps A Mohamed, QF Lin, HE Eaton, M Shmulevitz Journal of Virology 97 (2), e00009-23, 2023 | 2 | 2023 |
